APA

Meulendijks D., Lassen U. N., Siu L. L., Huitema A. D. R., Karanikas V., Mau-Sorensen M., Jonker D. J., Hansen A. R., Simcox M. E., Schostack K. J., Bottino D., Zhong H., Roessler M., Vega-Harring S. M., Jarutat T., Geho D., Wang K., DeMario M., Goss G. D. & Schellens J. H. M. (20161103). Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Meulendijks Didier, Lassen Ulrik N, Siu Lillian L, Huitema Alwin D R, Karanikas Vaios, Mau-Sorensen Morten, Jonker Derek J, Hansen Aaron R, Simcox Mary E, Schostack Kathleen J, Bottino Dean, Zhong Hua, Roessler Markus, Vega-Harring Suzana M, Jarutat Tiantom, Geho David, Wang Karen, DeMario Mark, Goss Glenwood D and Schellens Jan H M. 20161103. Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Meulendijks D., Lassen U. N., Siu L. L., Huitema A. D. R., Karanikas V., Mau-Sorensen M., Jonker D. J., Hansen A. R., Simcox M. E., Schostack K. J., Bottino D., Zhong H., Roessler M., Vega-Harring S. M., Jarutat T., Geho D., Wang K., DeMario M., Goss G. D. and Schellens J. H. M. (20161103). Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Meulendijks Didier, Lassen Ulrik N, Siu Lillian L, Huitema Alwin D R, Karanikas Vaios, Mau-Sorensen Morten, Jonker Derek J, Hansen Aaron R, Simcox Mary E, Schostack Kathleen J, Bottino Dean, Zhong Hua, Roessler Markus, Vega-Harring Suzana M, Jarutat Tiantom, Geho David, Wang Karen, DeMario Mark, Goss Glenwood D and Schellens Jan H M. Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20161103.